Myfreesia (Ethinylestradiol, Levonorgestrel)

Myfreesia, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

• Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed.
• Management of menstrual disorders: helps regulate menstrual cycles and reduce heavy bleeding.
• Treatment of acne: may improve acne associated with hormonal fluctuations.

• Ethinylestradiol and levonorgestrel act together to suppress the hypothalamic‑pituitary‑ovarian axis, inhibiting the mid‑cycle surge of luteinizing hormone and preventing ovulation. The estrogen component stabilises the endometrial lining, while the progestin thickens cervical mucus and induces endometrial changes that impede sperm penetration and implantation.

Common Side Effects

• Nausea: mild to moderate stomach upset, especially during the first cycles.
• Headache: tension‑type or migraine‑like headaches may occur.
• Breast tenderness: transient swelling or discomfort of the breasts.
• Spotting or breakthrough bleeding: irregular bleeding between periods.
• Weight gain: modest fluid retention or appetite changes.
• Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects

• Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.
• Stroke: ischemic or hemorrhagic cerebrovascular events.
• Myocardial infarction: heart attack, particularly in high‑risk women.
• Severe hypertension: sudden increase in blood pressure.
• Liver tumor: benign hepatic adenoma.
• Anaphylaxis: rare severe allergic reaction.

Before prescribing Myfreesia, clinicians should consider several safety factors.

• Assess cardiovascular risk: evaluate history of thromboembolic events or clotting disorders.
• Screen smoking status: avoid use in women over 35 who smoke.
• Review hepatic function: adjust or avoid in significant liver disease.
• Consider drug interactions: avoid concomitant enzyme‑inducing agents that may lower efficacy.
• Pregnancy contraindication: do not use during pregnancy or while attempting conception.
• Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Myfreesia may interact with several medicines that alter hormone levels.

Major Interactions (Avoid)

• Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): markedly reduce contraceptive effectiveness.
• Rifampin and other rifamycins: decrease plasma concentrations of estrogen and progestin.
• St. John’s wort: herbal inducer that can lower hormonal exposure.

Moderate Interactions (Monitor Closely)

• Certain antibiotics (e.g., tetracycline, metronidazole): may slightly diminish contraceptive effect.
• Antifungal agents (e.g., ketoconazole, itraconazole): can increase hormone levels, raising side‑effect risk.
• Selective serotonin reuptake inhibitors (SSRIs): may affect bleeding patterns and require monitoring.